glp 1 drugs and multiple sclerosis GLP-1 Drugs: For Chronic Conditions GLP-1 drug enters trial for

Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months

And with its FDA Category 2 classification, sourcing pharmaceutical-grade AOD-9604 has become increasingly difficult

Here's what you can expect during your treatment

CJC-1295 can be used in cycles, such as 12 weeks on and 4 weeks off, or as part of a long-term protocol, depending on your goals and your doctors assessment